Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention

Abstract

Pretreatment with atorvastatin 40 mg/d for 7 days significantly reduces procedural myocardial injury in elective coronary intervention. These results may influence practice patterns with regard to adjuvant pharmacological therapy before percutaneous revascularization.